MRTX0902 drug page Clinical trials

Trials with MRTX0902

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
2Countries
228Planned patients

Showing 1–1 of 1

A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Finished Phase 1 228 patients NCT05578092

This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX0902 alone and in combination with MRTX849 (adagrasib) in patients with advanced solid tumor malignancy harbori…

United States, Puerto Rico Dec 2022 – Jul 2026 Interventional
Combined with: Adagrasib